We are live on ! Find out more
AC

AltraVue Capital Portfolio holdings

AUM $1.16B
1-Year Est. Return 46.45%
This Fund
S&P 500
This Quarter Est. Return
-2.64%
1 Year Est. Return
+46.45%
3 Year Est. Return
+174.8%
5 Year Est. Return
+275.78%
10 Year Est. Return
AUM
$997M
AUM Growth
-$204M
Cap. Flow
-$148M
Cap. Flow %
-14.81%
Top 10 Hldgs %
62.26%
Holding
28
New
1
Increased
6
Reduced
17
Closed
1

Top Buys

Rank Stock Value
1
TRIP icon
TripAdvisor
TRIP
+$12.2M
2
UNH icon
UnitedHealth
UNH
+$7.09M
3
IIIV icon
i3 Verticals
IIIV
+$5M
4
TFIN icon
Triumph Financial Inc
TFIN
+$3.85M
5
PLUS icon
ePlus
PLUS
+$2.24M

Top Sells

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$88.5M
2
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$46.9M
3
IESC icon
IES Holdings
IESC
+$8.82M
4
AGX icon
Argan
AGX
+$4.17M
5
SNEX icon
StoneX
SNEX
+$3.95M

Sector Composition

Rank Sector Weight
1 Financials 24.27%
2 Technology 20.73%
3 Industrials 19.87%
4 Consumer Discretionary 13.68%
5 Healthcare 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRIP icon
26
TripAdvisor
TRIP
$1.65B
$11M 1.11%
+778,240
New +$12.2M
JBI icon
27
Janus International
JBI
$700M
$10.4M 1.04%
1,445,050
-148,020
-9% -$1.18M
CDMO
28
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
-3,797,813
Closed -$46.9M

Similar funds

AltraVue Capital's Q1 2025 Portfolio in Review

As of Q1 2025, AltraVue Capital held 28 positions worth $997M, down 17% from $1.2B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

AltraVue Capital withdrew a net $148M in Q1 2025, closing 1 position and reducing 17 holdings. Its most notable exit was Avid Bioservices, Inc. Common Stock, an estimated $46.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.

Against the trend, AltraVue Capital opened a new position in TripAdvisor worth $11M.

  • AltraVue Capital's largest Q1 2025 buy was TripAdvisor: 778,240 shares worth $11M.
  • AltraVue Capital added most to UnitedHealth in Q1 2025, an estimated $7.09M increase.
  • AltraVue Capital's biggest Q1 2025 reduction was Palantir, cutting an estimated $88.5M.
  • AltraVue Capital fully exited Avid Bioservices, Inc. Common Stock in Q1 2025, selling an estimated $46.9M.
  • AltraVue Capital's ten largest holdings make up 62% of its $997M portfolio in Q1 2025.
  • AltraVue Capital opened 1 new position and closed 1 in Q1 2025.
  • AltraVue Capital's portfolio value fell 17% quarter-over-quarter to $997M.

Based on AltraVue Capital's 13F filing for Q1 2025, filed 13 May 2025.